Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.48 | N/A | +21.52% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.48 | N/A | +21.52% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the earnings beat, highlighting their commitment to efficiency. They maintained a cautious outlook without providing specific guidance.
We are pleased with our EPS performance this quarter.
Our focus remains on maintaining operational efficiency.
The strong EPS performance indicates that Prestige Consumer HE is managing costs effectively and generating profit growth. The stock's 12.17% increase reflects investor confidence in the company's ability to deliver results. However, the lack of revenue data and future guidance leaves some uncertainty about overall performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
FABRINET
Feb 2, 2015